Determination and Validation of UV Spectrophotometer for the Antihypertensive Drug
Received Date: Nov 11, 2023 / Accepted Date: Nov 29, 2023 / Published Date: Nov 30, 2023
Abstract
Rapid and sensitive UV Spectrophotometric approach for regular assessment of hypertensive medication. For the assessment of drugs in their formulation, a brand-new, secure, and sensitive method of spectrophotometric estimate in the UV-region has been created. The analysis’s complete set of parameters were selected in accordance with ICH guidelines and statistically confirmed. System suitability, specificity, precision linearity, accuracy, intraday and interday assays, robustness, ruggedness, LOD, and log experiments were done. There was no excipient or other additive interference while calculating the Commercial Formulation.
Citation: Navale SA, Valekar DD, Patil KS (2023) Determination and Validation ofUV Spectrophotometer for the Antihypertensive Drug. J Anal Bioanal Tech 14: 579.
Copyright: © 2023 Navale SA, et al. This is an open-access article distributedunder the terms of the Creative Commons Attribution License, which permitsunrestricted use, distribution, and reproduction in any medium, provided theoriginal author and source are credited.
Share This Article
Open Access Journals
Article Usage
- Total views: 568
- [From(publication date): 0-0 - Nov 21, 2024]
- Breakdown by view type
- HTML page views: 521
- PDF downloads: 47